VANCOUVER, B.C. – Virogin Biotech, a clinical-stage biotech company is pleased to announce that their Investigational New Drug (IND) application for VG201 has been granted by the U.S. Food and… Read More
VANCOUVER, B.C. & SEATTLE — Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that management will participate in upcoming investor conferences. Guggenheim Oncology Conference 2022. Zymeworks will participate… Read More
VANCOUVER, B.C. — Following the closing of its US$7.3M Series A raise in December 2021, the Sonic Incytes Medical Corp. Board of Directors is pleased to announce the appointment of Barry… Read More
BayMedica’s VP of Commercial Operations, Chris Meiering, joins Shadd Dales of The Dales Report to talk about the growth opportunities in the cannabinoid industry. In the interview, Chris talks about… Read More
New government program enables access to integrated hybrid closed loop technology for 18 and under BRAMPTON, O.N. — Medtronic Canada ULC, a subsidiary of Medtronic plc (NYSE: MDT), a global leader… Read More
